Skip to main
KMB
KMB logo

Kimberly-Clark (KMB) Stock Forecast & Price Target

Kimberly-Clark (KMB) Analyst Ratings

Based on 9 analyst ratings
Hold
Strong Buy 0%
Buy 33%
Hold 56%
Sell 0%
Strong Sell 11%

Bulls say

Kimberly-Clark maintains a strong market position in the tissue and hygiene sector, with more than half of its sales derived from personal care products and an additional third from consumer tissue offerings. The company plans to leverage a robust innovation pipeline in 2026, which is expected to enhance its competitive edge and allow for technological advancements to be cascaded across product tiers. With a diverse geographic sales distribution—over 50% in North America and significant portions in Europe, Asia, and Latin America—Kimberly-Clark is well-positioned to capitalize on growth opportunities across multiple markets.

Bears say

Kimberly-Clark is experiencing a significant downturn, with a projected -4.0% decline in organic sales for the third quarter of 2025, impacting its overall growth outlook. Additionally, the company has reported a -2.7% decrease in US measured retail sales year-to-date for the same period. Consequently, earnings per share (EPS) estimates have been revised downward, with projections for fiscal year 2025 adjusted from $7.60 to $7.41 and for 2026 adjusted from $8.00 to $7.85, indicating ongoing financial challenges.

Kimberly-Clark (KMB) has been analyzed by 9 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 33% recommend Buy, 56% suggest Holding, 0% advise Selling, and 11% predict a Strong Sell.

This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Kimberly-Clark (KMB) Forecast

Analysts have given Kimberly-Clark (KMB) a Hold based on their latest research and market trends.

According to 9 analysts, Kimberly-Clark (KMB) has a Hold consensus rating as of Oct 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $137, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $137, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Kimberly-Clark (KMB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.